| 发明名称 |
USE OF IMMUNOREGULATORY ANTIBODIES IN THE TREATMENT OF NEOPLASTIC DISORDERS |
| 摘要 |
A combination antibody therapy for treating B cell malignancies using an immunoregulatory antibody, especially an anti-B7, anti-CD23, or anti-CD40L antibody and a B cell depleting antibody, especially anti-CD19, anti-CD20, anti-CD22 or anti-CD37 antibody is provided. Preferably, the combination therapy will comprise anti-B7 and anti-CD20 antibody administration.
|
| 申请公布号 |
WO02060485(A9) |
申请公布日期 |
2004.04.01 |
| 申请号 |
WO2002US02621 |
申请日期 |
2002.01.31 |
| 申请人 |
IDEC PHARMACEUTICALS CORPORATION;HARIHARAN, KANDASAMY;HANNA, NABIL |
发明人 |
HARIHARAN, KANDASAMY;HANNA, NABIL |
| 分类号 |
A61J1/00;A61K39/395;A61K45/00;A61K51/00;A61P7/00;A61P9/00;A61P31/18;A61P35/00;A61P35/02;C07K16/28;(IPC1-7):A61K45/00;A61K45/06 |
主分类号 |
A61J1/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
